Research Library

The science behind what changes after 40—and what the evidence actually tells us.

This library brings together published research on perimenopause, menopause, and later midlife across sleep, metabolic health, bone, muscle, cognition, sexual wellness, cardiovascular health, and healthy aging.

It separates stronger evidence from emerging evidence and names the limits of each study. The goal is not a miracle fix or a single answer—just a clearer way to read what research says.

Start with the question

Browse by topic

Begin with the area that feels most relevant. Each section keeps the language plain at the doorway, then shows the study population, finding, and limitation beneath it.

How to read this library

The studies below are primarily human observational research. That makes them useful for seeing patterns across time and populations, but it does not turn an association into a cause or a study result into a personal forecast.

Human clinical evidence Outcomes measured in people in a clinical or population study.
Observational evidence Researchers observe patterns without assigning an intervention.
Preclinical evidence Laboratory or animal work that comes before human confirmation.
Mechanistic/emerging research Early work about how a process may operate, not a settled outcome.

The transition has more than one pattern

Hormonal Transition

Estradiol and follicle-stimulating hormone do not move in one identical sequence for every woman. Research helps explain why timing, body composition, and background matter when we talk about the years around the final menstrual period.

Optional context: Perimenopause Stages and Menopause.

Observational evidence 2012
The Journal of Clinical Endocrinology & Metabolism

Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN).

Authors: Tepper PG, Randolph JF Jr, McConnell DS, et al.

Population
Women aged 42–52 from seven SWAN sites, followed for up to 11 annual visits and included after a natural, dateable final menstrual period.
What it found
The study identified four estradiol trajectories and three FSH trajectories. Patterns differed across race/ethnicity and body-mass groups.
Limitation
This describes hormone patterns in a cohort; it cannot prove that body size or race/ethnicity caused an individual trajectory or predict one woman's course.
Read the PubMed record · PMID: 22659249

Sleep is part of the transition story

Sleep

Sleep changes can show up before, during, and after the final menstrual period. The research points to different patterns rather than one universal sleep experience, with vasomotor symptoms and pre-existing sleep difficulty often traveling alongside it.

Optional context: Sleep & Stress.

Observational evidence 2017
Current Sleep Medicine Reports

Sleep Trajectories Before and After the Final Menstrual Period in The Study of Women's Health Across the Nation (SWAN).

Authors: Kravitz HM, Janssen I, Bromberger JT, et al.

Population
1,285 naturally menopausal women in SWAN, assessed from baseline through as many as 13 annual or biennial follow-ups.
What it found
Four trajectories of waking several times per night appeared. Sleep problems increased overall, while frequent vasomotor symptoms and other sleep complaints were associated with persistent difficulty.
Limitation
Trajectory modeling shows patterns and associations, not cause. The analysis also relied on reported sleep symptoms rather than a complete objective sleep assessment.
Read the PubMed record · PMID: 28944165

Body composition is not one number

Metabolism

Midlife metabolic research often looks at where fat is stored, how hormones relate to that pattern, and how age and body composition overlap. Those are useful clues, but they are not a single explanation for every metabolic change.

Optional context: Metabolic Health.

Observational evidence 2010
Obesity (Silver Spring)

Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.

Authors: Janssen I, Powell LH, Kazlauskaite R, Dugan SA.

Population
359 women aged 42–60 from the Chicago SWAN site, including 47.2% Black women, with visceral fat measured by CT at baseline.
What it found
Bioavailable testosterone was associated with visceral fat after adjustment for age, race, total body fat, and other cardiovascular risk factors. The association was stronger than the one seen for estradiol in this analysis.
Limitation
This was a baseline, cross-sectional ancillary analysis. It cannot establish that testosterone caused fat distribution or determine what would change an individual's metabolic risk.
Read the PubMed record · PMID: 19696765

Strength and bone have different clocks

Muscle & Bone

The years around menopause matter for both strength and bone density, but the readouts are different. The most useful studies measure each one directly and show when change appears—not what a single number is supposed to mean for every woman.

Optional context: Bone Density in Postmenopause.

Observational evidence 2004
American Journal of Epidemiology

The effect of menopause on grip and pinch strength: results from the Chicago, Illinois, site of the Study of Women's Health Across the Nation.

Authors: Kurina LM, Gulati M, Everson-Rose SA, et al.

Population
563 women from the Chicago SWAN site, followed with data collected between 1996 and 2001 for three-year changes in grip and pinch strength.
What it found
Women who became postmenopausal had lower adjusted grip and pinch strength than women who remained premenopausal; physical activity was the strongest predictor of strength.
Limitation
The observational design cannot fully separate hormonal transition from aging or establish why strength changed. The grip result was less statistically certain than the pinch result.
Read the PubMed record · PMID: 15321846
Observational evidence 2012
Journal of Bone and Mineral Research

Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).

Authors: Greendale GA, Sowers M, Han W, et al.

Population
862 women from a multiethnic SWAN cohort who were pre- or early perimenopausal at baseline and later had a dateable final menstrual period.
What it found
Bone-density loss began about one year before the final menstrual period and was greatest from one year before through two years after it, at both the lumbar spine and femoral neck.
Limitation
This cohort describes timing of bone-density change; it cannot establish the cause of loss or predict an individual's fracture risk from timing alone.
Read the PubMed record · PMID: 21976317

A difficult season is not the same as a permanent decline

Brain & Cognition

Midlife cognition research is more specific than the shorthand that women often hear. It looks at measured memory and processing tasks, when performance changes, and whether those changes persist beyond the transition.

Optional context: Brain Health.

Observational evidence 2009
Neurology

Effects of the menopause transition and hormone use on cognitive performance in midlife women.

Authors: Greendale GA, Huang MH, Wight RG, et al.

Population
2,362 SWAN participants followed for four years, with repeated measures of processing speed, verbal memory, and working memory.
What it found
Average improvement on some tasks paused during late perimenopause, while performance returned toward premenopausal levels after the transition in this cohort.
Limitation
These were observational test scores, not a diagnosis or a measure of dementia risk. Hormone use was not randomly assigned, so the study cannot establish a causal effect.
Read the PubMed record · PMID: 19470968

Sexual wellness is multidimensional

Sexual Health

Desire, arousal, comfort, pleasure, relationships, and vaginal symptoms do not move as one outcome. Research in midlife women is most useful when it keeps those dimensions separate instead of reducing sexual wellness to a single hormone story.

Optional context: Sexual Wellness.

Observational evidence 2018
Menopause

Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN).

Authors: Avis NE, Zhao X, Johannes CB, et al.

Population
3,167 women aged 42–52 in the SWAN baseline cohort, pre- or early perimenopausal, not using hormones, across five racial and ethnic groups.
What it found
Early perimenopausal women reported more pain with intercourse than premenopausal women, but not lower desire, arousal, frequency, or satisfaction. Relationship factors, vaginal dryness, and attitudes were strongly associated with outcomes.
Limitation
The baseline analysis was cross-sectional and self-reported. It cannot establish that the transition caused pain or explain how sexual function changes for every woman over time.
Read the PubMed record · PMID: 30358720

Age and reproductive stage overlap

Cardiovascular Health

Cardiovascular health changes during the same years that reproductive aging is changing. Good research asks how much of a shift tracks with chronological age, how much tracks with time since the final menstrual period, and which measures are actually being observed.

Optional context: Metabolic Health.

Observational evidence 2022
BMC Medicine

Cardiovascular health in the menopause transition: a longitudinal study of up to 3892 women with up to four repeated measures of risk factors.

Authors: Clayton GL, Soares AG, Kilpi F, et al.

Population
1,702 women with a natural menopause in a UK pregnancy-based cohort, measured up to four times from mean age 51 to 56; a wider stage analysis included 3,892 women.
What it found
Time since the final menstrual period was not strongly associated with carotid intima-media thickness beyond chronological age. Reproductive age was more clearly associated with modest changes in fat mass and glucose.
Limitation
This was an observational UK cohort using risk factors and a vascular measure rather than cardiovascular events. It cannot prove causation or rule out every form of risk.
Read the PubMed record · PMID: 35974322

Healthspan is more than one biomarker

Healthy Aging

Healthy aging research usually combines survival with memory, physical function, mental health, or freedom from major disease. That broader view is a useful guardrail against treating one lab value as the definition of a woman's future.

Optional context: Menopause.

Observational evidence 2018
Preventive Medicine Reports

Social integration and healthy aging among U.S. women.

Authors: Li S, Hagan K, Grodstein F, VanderWeele TJ.

Population
Women in the U.S. Nurses' Health Study who had no major chronic disease in 1996; 41,013 surviving women with 2012 outcome data were aged 66–91, and 6,206 met the study's healthy-aging definition.
What it found
Women who were more socially integrated in midlife had better odds of meeting the study's combined healthy-aging criteria after 16 years of follow-up.
Limitation
The association came from an observational survivor cohort and a composite definition of healthy aging. It cannot prove that social integration caused later health or apply equally to every population.
Read the PubMed record · PMID: 29527467

Scope & limits

Research is a starting point, not a promise.

This library summarizes published studies so readers can see what was measured, in whom, and with what level of certainty. Eterna Femme does not provide, prescribe, or substantiate treatments through these research summaries. A study result does not establish that a finding applies to every woman, that one factor caused another, or that an intervention is safe or effective for an individual. For personal questions, speak with a qualified clinician.